This study considered mortality trends for ischaemic heart disease and stroke using data from 102 continuous disease surveillance points from 1991 to 2009. Methods We analysed 102 continuous disease surveillance points, covering 7·3 million people in 1991–2000 and expanded to a population of 52·0...
For this aim, we proposed capturing the origin of ergodicity-breaking in many biological processes: cascade dynamics. To assess our hypotheses, we embraced the challenge of identifying reliable biomarkers for heart disease and stroke, which, despite being the leading cause of death worldwide and ...
bloodstream and cut off the blood flow when they get stuck in your blood vessels. As a result the specific organ no longer receives vital oxygen. In case of a pulmonary embolism for example, a blood clot blocks a blood vessel in the lungs, a stroke means there’s a blockage in the ...
J. et al. Heart disease and stroke statistics—2019 update: a report from the American Heart Association. Circulation 139, e56–e528 (2019). Article Google Scholar Gao, Z., Chen, Z., Sun, A. & Deng, X. Gender differences in cardiovascular disease. Med. Nov. Technol. Devices 4, ...
Download and install Help Center Adobe Support Community Enterprise Support Genuine software Resources Adobe Blog Adobe Developer Adobe Account Log in to your account Featured products Adobe Acrobat Reader Adobe Express Photoshop Illustrator Change region ...
With respect to cardiac contributions to exercise capacity, women exhibited lower stroke volumes, heart rates, and Fick CO augmentation with exercise as well as worse diastolic reserve (PCWP/CO slope) and LV reserve (ΔLVEF) (Table 2). Finally, women exhibited lower peripheral oxygen extraction ...
Super-Short Summary On February the 20th, 2016, I had a mild ischemic stroke — while resting at home for the weekend. A CAT Scan showed no damage in the brain, whereas the MRI showed many small specs, clear evidence of a stroke in the left frontal lobe.
Various polymer- and lipid-based NO donor carriers have shown some benefits in promoting vasodilation in stroke [20], restoring glucose homeostasis [21] or treating cancer [22, 23], yet not related to septic cardiomyopathy management. As known, the NO serves as a cellular messenger in living ...
Empagliflozin was well tolerated; serious adverse events were reported in 32.3% and 43.6% of the empagliflozin- and placebo-treated patients, respectively. These findings indicate that initiation of empagliflozin in patients hospitalized for acute heart failure is well tolerated and results in significant...
J. et al. Heart disease and stroke statistics — 2017 update: a report from the American heart association. Circulation 135, e146–e603 (2017). Article PubMed PubMed Central Google Scholar Darby, S. C. et al. Risk of ischemic heart disease in women after radiotherapy for breast ...